Skip to main content
. 2016 Feb 25;7(3):316–319. doi: 10.1007/s13193-016-0515-3

Table 4.

Tumour cells positive for ER/PR before chemotherapy for all receptor positive tumours

Receptor 1–39 % positivity 40–59 % positivity 60–79 % positivity 80–100 % positivity
ER (n = 37) 6 (16.2 %) 7 (18.9 %) 9 (24.3 %) 15 (40.5 %)
PR (n = 37) 8 (21.6 %) 9 (24.3 %) 11 (29.7 %) 9 (24.3 %)